Nardev Ramanathan is an associate research director and leads Lux Research’s coverage of Consumer Health Sciences as part of the CPG team. In this role, Nardev works closely with senior innovation leaders across the globe to guide and shape their corporate innovation strategies around new and emerging consumer health technologies, such as digital biomarkers, digital therapeutics, health wearables, AI in consumer health, and consumer genomics. As one of the senior members of the CPG team, he is also involved in planning the research agenda for the CPG team with other research leaders and more broadly supports cross-functional research related to the intersection between food, nutrition and agricultural innovation impact consumer health, working with subject matter experts across Lux.
Prior to joining Lux, Nardev was the assistant head of the Industrial Development Group at the Agency for Science, Technology and Research (A*STAR), Singapore, where he was the precision medicine and digital health lead. In that role, he helped develop an industry consortium to support Singapore’s biotech ecosystem for precision-medicine-related initiatives, leading to many successful partnerships with tangible outcomes.
Nardev earned his Ph.D. in Clinical Biochemistry from the University of Cambridge on an A*STAR Overseas Ph.D. scholarship. For his doctoral thesis, he identified a novel genetic mutation responsible for a rare inherited disease called lipodystrophy in a patient in the Middle East and went on to elucidate the molecular mechanism underlying the disease. Nardev has authored multiple peer-reviewed publications around metabolic health topics, many of which continue to be highly cited.